Abnormally expanded CAG/CTG repeat DNA sequences lead to a variety of neurological diseases, such as Huntington's disease.Here, we synthesized a cyclic pyrrole-imidazole polyamide (cPIP), which can bind to the minor groove of the CAG/CTG DNA sequence. The double-stranded DNA melting temperature (T m ) and surface plasmon resonance assays revealed the high binding affinity of the cPIP. In addition, next-generation sequencing showed that the cPIP had high specificity for its target DNA sequence.Although DNA repeat sequences are normally present in the human genome, abnormally elongated repeats can lead to a variety of diseases. [1,2] The abnormal elongation of CAG/CTG repeat sequences causes Huntington's disease, spinocerebellar ataxia, and myotonic dystrophy. Compounds that bind to the CAG/CTG repeat sequences have been studied to develop therapeutic agents for these neurological disorders. [3][4][5] Notably, Pearson et al. recently achieved a reduction in the number of repeats in vivo using a compound that binds to the hairpin structure formed by the CAG repeats. [6] These studies targeted the r(CUG) repeats [3,4] or d(CAG/CAG) hairpin structures in the CAG repeat regions, [5,6] whereas our group previously developed pyrrole-imidazole polyamides (PIPs) that bind to the d(CAG/ CTG) sequences in a sequence-specific manner. [7,8] PIPs are one of the well-studied DNA-binding compounds, which were developed by Dervan et al. [9,10] They bind to the minor groove of B-DNA, recognizing Watson-Crick base pairs by antiparallel pairings of their N-methylpyrrole (Py) and N-meth-[a] Y.